. 2014 Jan;80(1):154–165. doi: 10.1128/AEM.03108-13

TABLE 2.

E. faecalis isolates used in this study and their genomes

Group	Strain	Isolation origin(s)	MLST^a	Country^b	Yr^b	GenBank accession no.	Genome size^c (kb)	Reference(s)
NC	62	Human, healthy infant, feces	ST66	Norway	2002–2003	CP002491 to CP002495	3,131	55, 56
NC	D6	Pig	ST16	Denmark		ACAT00000000	2,887	48, 57
NC	E1Sol	Human, commensal isolate, feces	ST93	Solomon Islands	1960s	ACAQ00000000	2,853	48, 57
NC	Fly1	Drosophila, commensal isolate	ST101	USA	2005	ACAR00000000	2,791	48, 57
NC	R712	Human, feces	ST103	USA		ADDQ00000000	3,037	52
NC	S613	Human, feces	ST103	USA		ADDP00000000	3,042	52
NC	X98	Human, infant, feces	ST19		1934	ACAW00000000	2,910	48, 57
CL	AR01/DG	Dog, wound isolate, wound	ST108	New Zealand	2001	ACAK00000000	2,821	57
CL	ATCC 29200	Human, urogenital secretions	ST21	Canada	≤1974	ACHK00000000	2,936	52
CL	ATCC 29212	Human, urine	ST30	United Kingdom	≤1903	ALOD00000000	3,062	58
CL	ATCC 4200	Human, rheumatic fever isolate, blood	ST105		1926	ACAG00000000	3,009	48, 57
CL	CH188	Human, clinical isolate, liver	ST9	USA	1980s	ACAV00000000	3,159
CL	DAPTO 512	Human, clinical isolate, blood	ST103			AEBT00000000	3,054	52
CL	DAPTO 516	Human, clinical isolate, blood	ST103			AEBS00000000	3,055	52
CL	HH22	Human, clinical isolate, urinary isolates	ST6	USA	≤1982	ACIX00000000	3,050	59
CL	HIP11704	Human, clinical isolate	ST4	USA	2002	ACAN00000000	3,130	48, 57
CL	JH1	Human, clinical isolate	ST40	United Kingdom	≤1974	ACAP00000000	2,995	48, 57
CL	Merz96	Human, clinical isolate, blood	ST103	USA	2002	ACAM00000000	3,038	48, 57
CL	T11	Human, clinical isolate, urine	ST65	Japan	≤1992	ACAU00000000	2,729	48, 57
CL	T2	Human, clinical isolate, urine	ST11	Japan	≤1992	ACAE00000000	3,205	48, 57
CL	T3	Human, clinical isolate, urine	ST67	Japan	≤1992	ACAF00000000	2,784	48, 57
CL	T8	Human, clinical isolate, urine	ST8	Japan	≤1992	ACOC00000000	2,985	48, 57
CL	TUSoD Ef11	Human, cause of urinary tract infections, bacteremia, and infective endocarditis	ST364	USA		ACOX00000000	2,837	52
CL	TX0102	Human, clinical isolate, blood	ST21	USA		AEBD00000000	2,871	52
CL	TX0104	Human, endocarditis isolate	ST2	USA		ACGL00000000	3,107	6, 52
CL	TX0109	Human, clinical isolate, endocarditis, blood	ST59	USA		AEBY00000000	2,967	52
CL	TX0635	Human, clinical isolate, urogenital tract	ST9	USA		AEBZ00000000	3,168	52
CL	TX0855	Human, clinical isolate, urogenital tract	ST4	USA		AEBV00000000	2,986	52
CL	TX0860	Human, clinical isolate, catheter tip, blood	ST11	USA		AEBX00000000	3,062	52
CL	TX2134	Human, clinical isolate, GIT	ST30	USA		AEBW00000000	3,121	52
CL	TX4248	Human, clinical isolate, lymph node	ST40	USA		AEBR00000000	3,187	52
CL	V583	Human, hospitalized patient, blood	ST6	USA	1989	AE016830 to AE016833	3,360	60
	DS5		ST55		≤1974	ACAI00000000	3,128	48, 57
	OG1RF	Laboratory strain	ST1	USA	≤1975	CP002621	2,740	61
	T1	Human	ST21		≤1950	ACAD00000000	2,906	48, 57
	TX0411	Human	ST90	USA	1954	AECA00000000	3,124	52
	TX0470	Human	ST110	USA	1963	AECC00000000	2,877	52
	TX1322	Human	ST64	USA	1994	ACGM00000000	2,930	52

MLST were reassigned using each genome sequence used in this study. MLST of 26 isolates assigned by us were compared to reported MLST. All of them were the same as the reported MLST. MLST of 12 strains were assigned for the first time in this study.

Information on isolation country and year (6).

Genome sizes were calculated as the total length of contigs for each genome.